Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov;36(sup1):83-89.
doi: 10.1080/02656736.2019.1647356.

Temperature as a modulator of the gut microbiome: what are the implications and opportunities for thermal medicine?

Affiliations
Review

Temperature as a modulator of the gut microbiome: what are the implications and opportunities for thermal medicine?

Bonnie L Hylander et al. Int J Hyperthermia. 2019 Nov.

Abstract

There is substantial research being conducted on the relationships between the gut microbiome, the immune response and health and disease. Environmental temperature and heat stress are known to modify the gut microbiome. Changes in core temperature have been linked, in multiple phyla, to altered microbiome composition and function. This raises the question of whether local/regional or whole body thermal therapies which target tumors in the abdomen, peritoneal cavity, or pelvis influence the gut microbiome. To date, there is little information on whether thermal therapy exerts positive or negative effects on the microbiome. This is an intriguing question since there is growing interest in the immunological impact of various thermal therapies. The goal of this brief review is to highlight research on how environmental conditions, particularly temperature (internal as well as external temperatures) influences the gut microbiome. Given the potential for temperature shifts to modulate gut microbe function and composition, it is likely that various forms of thermal therapy, including hyperthermic intraperitoneal chemotherapy (HIPEC), deep regional, and whole body hyperthermia influence the microbiome in ways that are currently not appreciated. More research is needed to determine whether thermal therapy induced changes in the microbiome occur, and whether they are beneficial or detrimental to the host. Currently, although approaches to microbiome modification such as dietary intervention, fecal transfer, probiotics and prebiotics are being developed, the potential of temperature manipulation has, as yet, not been explored. Therefore, new research could reveal whether perturbations of the microbiome composition that have negative health consequences (dysbiosis) could be an important target for treatment by thermal medicine.

Keywords: Microbiome; hyperthermia; immune response; temperature; thermal therapy.

PubMed Disclaimer

Conflict of interest statement

Disclosure of Interest: The authors report no conflict of interest.

Figures

Figure 1.
Figure 1.
Under normal conditions, the microbiome and the immune system interact to regulate each other and maintain a homeostatic balance. The composition of the microbiome is sensitive to environmental factors such as diet and a variety of other stressors (including temperature) and dysbiosis is associated with several disease states. It has been reported that the composition of the microbiome directly regulates response to anti-cancer chemotherapy and immunotherapy. However, the effect of thermal therapy of the microbiome and anti-tumor immune response is unknown.

References

    1. van der Zee J & van Rhoon GC Cervical cancer: radiotherapy and hyperthermia. Int J Hyperthermia 22, 229–234 (2006). - PubMed
    1. Issels RD, Lindner LH, Verweij J, Wessalowski R, Reichardt P, Wust P, Ghadjar P, Hohenberger P, Angele M, Salat C, Vujaskovic Z, Daugaard S, Mella O, Mansmann U, Durr HR, Knosel T, Abdel-Rahman S, Schmidt M, Hiddemann W, Jauch KW, Belka C & Gronchi A Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial. JAMA Oncol 4, 483–492 (2018). - PMC - PubMed
    1. Mauri G, Nicosia L, Xu Z, Di Pietro S, Monfardini L, Bonomo G, Varano GM, Prada F, Della Vigna P & Orsi F Focused ultrasound: tumour ablation and its potential to enhance immunological therapy to cancer. Br J Radiol 91, 20170641 (2018). - PMC - PubMed
    1. Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, Sanders LL & Dewhirst MW Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23, 3079–3085 (2005). - PubMed
    1. Pavlov MJ, Ceranic MS, Latincic SM, Sabljak PV, Kecmanovic DM & Sugarbaker PH Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial and recurrent ovarian carcinoma: a single center experience. Int J Hyperthermia 34, 564–569 (2018). - PubMed

Publication types

LinkOut - more resources